Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

News Conference News TVT 2023

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

Shelley Wood

June 14, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

News Conference News TVT 2023

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

Shelley Wood

June 08, 2023

Presentation TVT 2023

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Presenter: Michael Mack

June 08, 2023

Presentation TVT 2023

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Presenter: Firas Zahr

June 08, 2023

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

Key features for a first valve in a low-risk patient

Presenter: Katherine Harrington

June 09, 2022

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Todd Neale

July 23, 2021

Presentation TVT 2021

Complete 2-year Follow-Up from Evolut Low Risk Trial

Presenter: John Forrest

July 20, 2021

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

Presentation TVT 2021

TAVR and SAVR “Sequencing”: Lifelong Management Journey of Severe AS

Presenter: Isaac George

July 20, 2021

Presentation TVT 2021

Choosing the First TAVR Prosthesis: Self Expanding vs Balloon Expandable – Advantages and Disadvantages

Presenter: Uri Landes

July 20, 2021

Presentation TVT 2021

Clinical and Anatomic Considerations for TAVR in a Young Patient (<65 yo): Durability, Coronary Access, and More

Presenter: Gilbert Tang

July 20, 2021

Presentation TVT 2021

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Presenter: John Forrest

July 20, 2021

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Conference News TVT 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Shelley Wood

June 24, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Michael O'Riordan

June 21, 2020

Advertisement

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Key features for a first valve in a low-risk patient

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Complete 2-year Follow-Up from Evolut Low Risk Trial

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

TAVR and SAVR “Sequencing”: Lifelong Management Journey of Severe AS

Choosing the First TAVR Prosthesis: Self Expanding vs Balloon Expandable – Advantages and Disadvantages

Clinical and Anatomic Considerations for TAVR in a Young Patient (<65 yo): Durability, Coronary Access, and More

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content